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KESAN FRAKSI YANG KAYA DENGAN PROTEIN DARI L. PLANTARUM 
USM8613 DALAM MELAWAN PATOGEN KULIT STAPHYLOCOCCUS 
AUREUS 
ABSTRAK 
Tiga puluh enam strain bakteria asid laktik telah diasingkan daripada tenusu, 
daging dan produk penapaian tempatan. Ekstrak extrasel (CFS) daripada L. plantarum 
USM8613, yang didapati daripada sosej yang ditapai, menunjukkan aktiviti perencatan 
dan penghasilan asid laktik yang lebih tinggi (ρ < 0.05) telah dipilih untuk analisis 
seterusnya. Kajian ex-vivo menunjukkan CFS daripada L. plantarum USM8613 
berupaya merencatkan pembentukan biofilem dan pertumbuhan S. aureus pada kulit 
khinzir. Fraksi yang kaya dengan protein, lemak dan polisakarida yang diekstrak 
daripada CFS L. plantarum USM8613 telah diuji untuk aktiviti perencatan. Kajian 
menunjukkan fraksi yang kaya dengan protein memberi kesan yang lebih ketara 
berbanding dengan fraksi yang kaya lemak and polisakarida. Fraksi yang kaya dengan 
protein dari L. plantarum USM8613 juga berupaya merencatkan (ρ <0.05) pertumbuhan 
S. aureus klinikal dan pembentukan biofilem pada kulit khinzir. Rawatan topikal yang 
mengandungi 800 AU/mL fraksi yang kaya dengna protein daripada L. plantarum 
USM8613 didapati berupaya mengurangkan (ρ < 0.05) bilangan sel S. aureus ditapak 
luka tikus. Penghasilan IL-4, IL-6, IFN-Ɣ, TGF-β dan TNF-α, juga dipertingkatkan (ρ < 
0.05) dengan rawatan fraksi yang kaya dengan protein tersebut. Fraksi yang kaya dengan 
protein juga berupaya meningkatkan ekspresi MMPs dan defensin-β. Keseluruhannya, 
kajian ini menunjukkan fraksi yang kaya deangan protein boleh menggalakkan 
penyembuhan luka dengan mengawal efektor sistem pertahanan badan yang terlibat 
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dalam penyembuhan luka. Kajian pengekspresan gen S. aureus menunjukkan gen stress 
regulator (sigB) dan autolysin utama (atl) telah meningkat (ρ < 0.05) sewaktu rawatan 
fraksi yang kaya dengan protein dan ini menyumbang kepada aktiviti perencatan fraksi 
yang kaya dengan protein daripada L. plantarum USM8613. Ekspresi gen faktor 
kevirulenan S. aureus (hla, hlb, spaV) telah disekat dengan rawatan fraksi yang kaya 
dengan protein daripada L. plantarum USM8613. Penggunaan strain mutan atl-null S. 
aureus mengesahkan lagi kesan perencatan fraksi yang kaya dengan protein daripada L. 
plantarum USM8613 dicapai dengan merangsangkan eskpresi gen autolysin utama, atl 
gen. Analisis genom keseluruhan menunjukkan L. plantarum USM8613 mempunyai 
genom bersaiz 3,258,106 bp yang mempamerkan adaptasi L. plantarum USM8613 untuk 
menggunakan pelbagai jenis sumber karbon dan asid amino daripada sekitar untuk 
kemandirian. Genom L. plantarum USM8613 mengandungi kesemua lima operon 
plantaricin dan kefungsian operon ini telah disahkan melalui analisis ekspresi gen. 
Secara keseluruhannya, hasil kajian ini menunjukkan keberkesanan fraksi yang kaya 
dengan protein daripada L. plantarum USM8613 dalam merencatkan pertumbuhan dan 
menyekat factor kevirulenan S. aureus, serta menggalakkan penyembuhan luka. Maka, 
fraksi yang kaya dengan protein dari L. plantarum USM8613 boleh digunakan sebagai 
bahan bioaktif dalam bidang dermatologi untuk merawat jangkitan S. aureus dan 
penjagaan luka. 
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EFFECTS OF PROTEIN-RICH FRACTION FROM LACTOBACILLUS 
PLANTARUM USM8613 AGAINST DERMAL STAPHYLOCOCCUS AUREUS 
ABSTRACT 
 Thirty-six strains of lactic acid bacteria were isolated from local dairy, meat and 
fermented products. Cell-free-supernatant (CFS) of L. plantarum USM8613, isolated 
from fermented sausage, was selected for subsequent analyses. The CFS exhibited a 
significantly stronger (ρ < 0.05) inhibitory activity against S. aureus and produced a 
higher amount of lactic acid as compared to all strains studied. Ex-vivo study 
demonstrated CFS from L. plantarum USM8613 inhibited the growth and biofilm 
formation of S. aureus on porcine skins. CFS of L. plantarum USM8613 was 
fractionated into protein-rich, lipid-rich and polysaccharide-rich fractions, and all 
fractions exhibited significant inhibitory activity, with a more prevalent effect from the 
protein-rich fraction. The antimicrobial and anti-biofilm effects of the protein-rich 
fraction were further confirmed with S. aureus-infected porcine skins. Topical 
application of ointment containing 800 AU/mL of the protein-rich fraction from L. 
plantarum USM8613 significantly reduced (ρ < 0.05) the cell counts of S. aureus in the 
wound site of S. aureus infected-rats. The production of IL-4, IL-6, IFN-Ɣ, TGF-β and 
TNF-α, and the expression of matrix metalloproteinases (MMPs) and β-defensin were 
also significantly elevated (ρ < 0.05) upon treatment with the protein-rich fraction. 
Altogether, it indicated that the protein-rich faction promoted wound healing by 
regulating the immune effectors involved in wound healing. Gene expression study of S. 
aureus showed the stress regulator gene (sigB) and the major autolysin gene (atl) were 
significantly up-regulated upon treatment with the protein-rich fraction and contributed 
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to the autolysis and cell death of S. aureus itself. Pathogenicity factors of S. aureus (hla, 
hlb, spaV genes) were also suppressed upon the protein-rich fraction treatment. The use 
of atl null mutant strain of S. aureus, which further justified the inhibitory effect of the 
protein-rich fraction from L. plantarum USM8613, was achieved via up-regulation of 
the major autolysin, atl gene. Genome-wide analysis revealed a genome size of 
3,258,106 bp of L. plantarum USM8613, demonstrating the adaption of L. plantarum 
USM8613 to utilise a large variety of carbon and amino acid sources from the 
surroundings for survival. The genome of L. plantarum USM8613 contained all five 
plantaricin operons and the functionality of these operons was confirmed via gene 
expression analysis. Altogether, results in this research demonstrated the protein-rich 
fraction from L. plantarum USM8613 effectively inhibited the growth and suppressed 
the pathogenicity of S. aureus, and promoted wound healing. Therefore, the protein-rich 
fraction from L. plantarum USM8613 could be applied as a bioactive agent in the 
dermatological industry for the treatment of S. aureus infection and wound healing. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 Background 
 Over the past 100 years, changes in society and technology have led to a change 
in lifestyle and resolved many basic life needs in many parts of the world. Meanwhile, 
these changes also brought about the renaissance of the old ones, creating new diseases 
and modification of existing dermatoses. Nowadays, the invention and extensive use of 
antibiotics have generated various antibiotics-resistant variants that gave rise to a new 
health risk (Padmanabhan & Fraser 2005; Amini et al. 2012, 2013). Lactic acid bacteria 
consist of Gram-positive, non-sporulating, microaerophilic bacteria that produce lactic 
acid as the main end product of carbohydrate fermentation. Lactic acid bacteria have a 
long history of use and play an important role in food industries due to their ability to 
exert various beneficial effects. For instance, the starter culture is used to improve the 
nutrient content, as well as preservatives to extend the shelf-life of food products 
(Caprice & Fitzgerald 1999; Jay 2000; Holzapfel et al. 2001). In addition to its additive 
effect to food content, the intake of lactic acid bacteria also confer health benefits to the 
host via improved gut ecosystem, reduced serum cholesterol and enhanced host immune 
system. Among them, members of the genera Lactobacillus are the most commonly and 
commercially used. Despite the long-term use of these beneficial lactobacilli in food 
industries, it was not until recently the use of lactobacilli had been extended to improve 
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dermal health. Several studies have suggested the use of these beneficial lactic acid 
bacteria to maintain cutaneous homeostasis and improve the regulation of the skin 
immune system (Kaliomake et al. 2001, 2003, 2007).  
 Various studies have reported that topical application where there is direct 
availability of the whole cells or metabolites from lactic acid bacteria to the skin could 
also improve dermal health (Krutmann 2009; Simmering & Breves 2009). Different 
approaches have been used by lactic acid bacteria to inhibit and out-compete the 
undesired species, for example competitive exclusion and production of various potent 
antimicrobial substances such as organic acids, bacteriocins, hydrogen peroxide and 
others (Oh et al. 2006; Gillor et al. 2008). Among the various potent antimicrobial 
substances produced by lactic acid bacteria, antimicrobial peptides have gained the most 
attention and are being extensively studied. Recent studies have revealed the ability of 
these proteinaceous compounds to exert wound healing properties in addition to its well-
known antimicrobial effects, where nisin and plantaricin A were shown to exert 
significant antimicrobial property and immunomodulating effects in S. aureus-induced 
skin infections in mice (Marzani et al. 2012; Heunis et al. 2013).  
 Skin is the largest organ in the human body, providing a physical barrier that 
protects against dehydration and damage or insults from external aggression. The skin is 
continuously challenged by diverse environmental stresses such as changes in climate 
conditions, mechanical damages, and the exposure to chemical and physical factors such 
as ultraviolet radical, free radicals, toxins, allergens, and xenobiotics, which are the 
major factors that alter skin integrity, leading to immune system dysfunction, 
inflammation, photoaging, and a variety of hyperplasia (Krutmann et al. 1996; 
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Scharffeter-Kochanek et al. 2000). The skin is naturally populated by various 
microorganisms, dominated by health-promoting microorganisms known as commensal 
microorganisms, against harmful microorganisms. An alteration in the skin barrier 
functions increases the risks of infection by those harmful microorganisms. Among the 
various forms of skin infections such as impetigo, folliculitis, furunculosis, ecthyma, and 
cellulitis, Staphylococcus aureus is one of the most common causative agents.  
 S. aureus is a transient opportunistic skin pathogen of human and various 
animals. The ability of S. aureus to survive in various adverse conditions enables it to 
inhabit various niches and is easily transmitted via skin-formit contact (Amini et al. 
2012, 2013; Tang et al. 2015). S. aureus is well-equipped with various virulence factors 
that causes mild to severe infections, ranging from cutaneous to systemic infections. In 
addition to virulence factors, S. aureus also contains several surface components such as 
Protein A and extracellular adhesion protein (Eap), which facilitate S. aureus to evade 
recognisation and phagocytosis and subsequently survive against the host immune 
system (Foster & McDevitt 1994; Chavakis et al. 2002; Lee et al. 2002). The invention 
and use of antibiotics to treat S. aureus have successfully controlled the threat. Recently, 
S. aureus was able to survive and be immune to the use of β-lactam antibiotics via the 
acquisition of the penicillin binding protein. The emergence of the antibiotics-resistant 
strains has further reduced the treatment and therapeutic options (Diekema et al. 2001; 
Foster 2005). Hence, there is a need for natural alternative compounds to treat S. aureus 
without causing the resistant issues.  
 To date, only limited studies have been conducted in direct topical application of 
extracts from lactic acid bacteria to exert antimicrobial activity against S. aureus and 
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improve dermal health. To further elucidate this assumption, more information regarding 
the production of the potential bioactive metabolites from lactic acid bacteria shall be 
gathered to fully understand the mechanism behind it. Moreover, the safety and efficacy 
of these bioactive metabolites need to be verified to provide a better understanding and 
compensate the scarce reports regarding the safety and efficacy issues. 
 
1.2 Aim and Objectives for Research 
 The main aim of this study was to evaluate the potential use of bioactive 
metabolites from locally isolated lactic acid bacteria on improving dermal health and 
fight against S. aureus. The regulation of the target pathogen upon treatment was also 
examined. Hence, the specific objectives of this study were: 
1. To isolate and identify potential lactic acid bacteria from local dairy, meat and 
fermented products. 
2. To evaluate and characterise the antimicrobial and anti-virulence activities of 
the fractionated extracts from the selected lactic acid bacteria. 
3. To evaluate the safety and efficacy of the fractionated extracts from the 
selected lactic acid bacteria via in-vivo models 
4. To investigate the expression of regulatory pathways of S. aureus upon 
treatment with the fractionated extracts from the selected lactic acid bacteria  
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5. To determine the potential bioactive metabolites encoding genes in the selected 
lactic acid bacteria responsible for the inhibitory activity via whole genome 
study. 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1 Lactic Acid Bacteria 
 Over the past century, lactic acid bacteria (LAB) have gained much attention 
from various communities due to their ability to exert various beneficial factors. LAB 
consist of a group Gram-positive, non-sporulating bacteria that produce lactic acid as the 
major end product of carbohydrate fermentation. LAB utilise carbohydrates as the major 
carbon and energy source either through homofermentative or heterofermentative 
pathway. Homofermenters utilise carbohydrate via the Embden-Meyerhof-Parnas 
pathway to produce lactic acid as the major product of fermentation, while 
heterofermenters use the 6-P-gluconate or phosphoketolase pathway for carbohydrates 
fermentation resulting in lactic acid, acetic acid or ethanol, and carbon dioxide as end 
products (König & Fröhlich 2009). The most commonly recognised lactic acid 
producing bacteria are from the genera Lactobacillus, Lactococcus, Bifidobacterium, 
Enterococcus, Leuconostoc, Pediococcus and Streptococcus (Jay 2000; Holzapfel et al. 
2001). Generally, LAB prefer to inhabit an area rich in nutrients, hence, they are widely 
distributed in dairy products, meats, plants, vegetables, fruits, fermented foods, 
beverages, decomposing materials, sewage, and also cavities of humans and animals 
such as mouth, genital, intestinal and respiratory tract as part of healthy microbiota 
(König & Fröhlich 2009).  
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LAB are commonly isolated from dairy products (Rodriguez et al. 2000; Martin 
et al. 2003). Raw milk is regarded as a source for isolation of new strains of LAB due to 
their potential to inhibit undesired microorganisms. For instance, LAB isolated from 
human breast milk can be potentially used as human probiotics due to their origin, 
history of safety, prolonged intake by infants, and adaptation to dairy substrates (Martin 
et al. 2003). Human gut and faecal samples are also regarded as a common source for 
isolation of LAB conferring health benefits (Pereira & Gibson 2002; Duncan et al. 2004). 
L. plantarum KC5b isolated from faecal sample of healthy human volunteers is regarded 
as a candidate probiotic due to its ability to remove a maximum of 14.8 mg of 
cholesterol per gram of cells from the culture medium (Pereira & Gibson 2002). Various 
LAB with probiotics characteristic also have been isolated from fermented meat 
products. Their presence in meat fermentations may improve the safety and stability of 
the product, and also enhance the sensory properties of the fermented meats (Lucke 
2000; Papamanoli et al. 2003). Papamanoli et al. (2003) reported L. sakei, L. curvatus 
and L. plantarum strains isolated from naturally fermented dry sausages are able to grow 
in environments that mimic human gut and inhibit the growth of two common food 
spoilage bacteria, Listeria monocytogenes and Staphylococcus aureus. 
 Numerous studies and reviews about LAB have been extensively reported. The 
use of LAB in food industries had begun after the in depth study by L. Pasteur in lactic 
acid fermentation and the isolation of the first pure culture by J. Lister. The use of LAB 
as starter culture or preservative in food fermentation began in 1890 (König & Fröhlich 
2009). The preservative effect of LAB is mainly due to the production of organic acids, 
especially lactic acid, which subsequently lowers the surrounding pH. The antimicrobial 
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effect of LAB is further enhanced by other antimicrobial compounds such as hydrogen 
peroxide, carbon dioxide, diacetyl, acetaldehyde, and bacteriocins (Klaenhammer 1988; 
Stiles & Hastings 1991; Klaenhammer 1993). In addition to their preservative action, the 
use of LAB in food industries is also due to their ability to enhance the texture, flavour, 
or nutrition of the foods. Among various lactic acid bacteria, member of the genera 
Lactobacillus was the most commonly used and studied.  
 2.1.1 Lactobacillus 
 The genus Lactobacillus was described as a heterogeneous group of “regular 
non-sporing Gram-positive rods” according to Bergey’s Manual of Systematic 
Bacteriology (Sneath et al. 1986).  Lactobacilli can be divided into three classes based 
on their fermentation characteristic: (1) obligate homofermentative; (2) facultative 
heterofermentative; and (3) obligate heterofermentative, as shown in Table 2.1.  
The homofermenter gains energy via Embden-Meyerhof-Panas pathway while 
heterofermenter gains energy via 6-P-gluconate or phosphoketolase pathway. They live 
widespread in various fermentable materials (Pot et al. 1994; Hammes & Vogel 1995; 
Vandamme et al. 1996). Among the members of lactobacilli, the most commonly 
recognised are L. delbrueckii, L. acidophilus, L. gasseri, L. casei, L. johnsonii, L. 
plantarum, L. reuteri, L. fermentum and L. brevis that are used in various food 
processing industries such as meat fermentation, dairy products, bakery, and beverages 
fermentation (Pot et al. 1993; Stâhl & Molin 1994; Holzapfel et al. 1996). Lactobacilli 
have been extensively used due to their ability to exert various health promoting effects 
and improve food quality. 
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Table 2.1 Major division within the genus Lactobacillus based on fermentation 
characteristic (Collin et al. 1991; Schleifer & Ludwig 1995). 
  
Group 1 Group 2 Group 3 
Obligate homofermenters 
Facultative 
heterofermenters 
Obligate heterofermenters 
L. acidophilus L. acetotolerans L. brevis 
L. amylophilus L. agilis L. buchneri 
L. amylovorus L. alimentarius L. collinoides 
L. aviarius subsp. 
araffinosus subsp. 
aviarius 
L. bifermentans L. fermentum 
L. crispatus L. casei L. fructivorans 
L. delbrueckii subsp. 
bulgaricus subsp. 
delbruekii subsp. lactis 
L. coryniformis subsp. 
coryniformis subsp. 
torquens 
L. fructosus 
L. farciminis L. curvatus L. hilgardii 
L. gallinarum L. graminis L. kefir 
L. gasseri L. hamsteri L. malefermentans 
L. helveticus L. homohiochii L. oris 
L. jensenii L. intestinalis L. panis 
L. johnsonii L. murinus L. parabuchneri 
L. kefiranofaciens 
L. paracasei subsp 
paracasei subsp. tolerans 
L. parakefir 
L. kefirgranum L. paraplantarum L. pontis 
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Table 2.1 Continued 
  
Group 1 Group 2 Group 3 
Obligate homofermenters 
Facultative 
heterofermenters 
Obligate heterofermenters 
L. mali L. pentosus L. reuteri 
L. ruminis L. plantarum L. sanfrancisco 
L. salivarius subsp. 
salicinus subsp. 
salivarius 
L. rhamnosus L. suebicus 
L. sharpeae L. sake L. vaccinostercus 
  L. vaginalis 
 
 
 
2.1.2 Conventional Health Benefits from Lactic Acid Bacteria 
 Lactic acid bacteria (LAB) have a long history of use in food fermentation and 
consumption to improve gut health. They are also the predominant members that are 
usually associated as probiotics and constitute approximately one-third of the bacterial 
population in the intestinal tract. Hence, LAB have been used as a guideline for the 
stability of healthy intestinal microbiota and for the prevention and treatment of various 
diseases (Kruis et al. 2004; Sazawal et al. 2006; Gawronska et al. 2007; Reyed 2007).  
 The production of antimicrobial substances such as bacteriocins and hydrogen 
peroxide by LAB contribute to the antagonist activity against various antibiotic-resistant 
strains. The use of antimicrobial substances is preferred against antibiotics due to their 
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long history of safe use in foods. For example, the production of plantaricin ZJ008 by L. 
plantarum ZJ008 was reported to be effective against various Staphylococcus spp., 
including the methicillin-resistant strains. The possible mode of action of plantaricin 
ZJ008 is via pore formation, subsequently causing leakage of K+ out of cells, thus 
contributing to bactericidal effect (Zhu et al. 2014). Meanwhile, hydrogen peroxide is a 
strong oxidiser produced by lactobacilli. For instance, hydrogen peroxide generated by L. 
gasseri, which is isolated from vaginal tract of cattle was reported to inhibit the growth 
of S. aureus (Otero & Nader-Macias 2006). Similar finding was reported by Pridmore et 
al. (2006), where the growth of Salmonella sp. was inhibited by the hydrogen peroxide 
produced by L. johnsonii NCC33. In addition, the production of these antimicrobial 
substances also confers a competitive advantage to the bacteriocin-producing bacteria, 
which further reduced the colonisation by antibiotic-resistant strains. 
 Despite direct action against the pathogenic strains, LAB also exert an indirect 
protective effects via stimulation of host immune system. The lipotechoic acid and 
peptidoglycan of LAB are detected by toll-like receptor 2 (TLR2) and peptidoglycan 
recognition proteins of the host immune system, leading to enhanced innate immunity 
and stimulation of immune response, such as initiating pro-inflammatory activities and 
enhancing the production of both cytokines and secretory immunoglobulin A (sIgA) 
(McDonald et al. 2005; Warchakoon et al. 2009; Brandt et al. 2013). The major role of 
cytokines is to activate the immune cells upon encountering pathogens and subsequently 
stimulate the immune response. Meanwhile, the main function of sIgA is in preventing 
the binding of foreign bacteria to the epithelial cells and penetration of harmful 
microorganisms (Erickson & Hubbard 2000). Upon encountering peptidoglycan from 
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LAB, the peptidoglycan recognition proteins will subsequently act as antibacterial 
molecules and activate the two-component systems, CssR-CssS or CpzA-CpxR. The 
activation of these systems will result in bacterial cell death via membrane 
depolarisation, increase the production of hydroxyl radical and cessation of DNA, RNA, 
and intracellular peptidoglycan synthesis (McDonald et al. 2005; Park et al. 2011). 
Furthermore, lipoteichoic acid isolated from L. rhamnosus GG was reported to enhance 
the pro-inflammatory activities in HEK293T cells by inducing IL-8 in intestinal cells 
and NF-KB activation via TLR2/6 interaction (Claes et al. 2012). 
In addition, the administration of certain LAB could ease antibiotic-associated 
diarrhoea and inflammatory bowel diseases such as ulcerative colitis and Crohn’s 
disease via regulating the intestinal microbiota and stabilise antibiotic induced dysbiosis 
as demonstrated by Lactobacillus GG (Zhang et al. 2005). Fung et al. (2011) suggested 
the possible approaches of LAB to inhibit the growth of intestinal pathogen that leads to 
inflammation via three possible mechanisms: the production of inhibitory substances, 
adherence to mucosal layer, and iron-siderophore. This indicates the ability of some 
LAB to protect gastrointestinal tract against the invasion of pathogens and subsequently 
lower the risk of infections, suggesting the potential use of lactobacilli as an alternative 
for antibiotic treatment, thus reducing the occurrence of antibiotic resistant. 
 LAB also have been found to alleviate lactose intolerance symptoms. Lactose 
maldigester may experience abdominal discomfort, bloating, diarrhea, and flatulence 
upon ingestion of sufficient amount of lactose (Vesa et al. 2000). Honda et al. (2007) 
demonstrated the ability of lactobacilli to exhibit β-galactosidase, phosphor-β-
galactosidase and phosphor-β-glucosidase activities that hydrolyse lactose via activating 
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two lactose transportation systems, namely lactose-permease transportation and lactose-
specific phosphoenolpyruvate-dependent phosphotransferase system. Another study also 
demonstrated oral administration of L. acidophilus and L. casei-fermented milk by 18 
lactase deficiency subjects alleviated the lactose intolerance symptoms, leading to an 
improvement in lactose digestion (Gaón et al. 1995).  
Another health benefit from the consumption of LAB is the reduction of serum 
cholesterol level. Several possible mechanisms were used to exert hypocholesterolemic 
effect such as assimilation by growing cells or through binding to the cell surface or 
incorporation into the cell membrane (Liong & Shah 2005a, 2005b). Serum cholesterol 
could also be reduced via bile salt hydrolase (BSH) to deconjugate bile salt and the 
resulting free bile salts have limited re-absorption in the gut and more easily to be 
excreted in the faeces due to poor solubilisation in the gastrointestinal tract. As a result, 
the demand for synthesise of new bile salt increases to replace those lost in faeces, 
resulting in the serum cholesterol lowering effect where cholesterol is the precursor for 
bile acids. Various in-vivo studies have been conducted, indicating the serum cholesterol 
lowering property of LAB, as shown by Shah (2007) where the administration of 
probiotic fermented milk (109 bacteria per mL) to hypercholesteromic human subject 
was capable of reducing 50% of serum cholesterol level. 
 Apart from serum cholesterol lowering property, LAB also contain blood 
pressure lowering ability. This ability is achieved through the production of release 
bioactive peptides, the angiotensin-I converting enzyme (ACE) inhibitory peptides that 
play a crucial role in the rennin-angiotensin system. Several in-vitro and in-vivo studies 
have been conducted to illustrate the blood pressure lowering on hypertension patients. 
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For example, Ong and Shah (2008) reported that the addition of L. casei and L. 
acidophilus in cheese production had a significantly higher production of ACE 
inhibitory peptides compared with those without the addition of probiotics. Similar 
findings were also observed in the studies by Donkor et al. (2007) and Rhyänen et al. 
(2001). In addition, an in vivo study by Jauhiainen et al. (2005) illustrated the 
consumption of L. helveticus-fermented milk twice a day for 10 weeks could decrease 
systolic blood pressure and diastolic blood pressure by 4.1 mm Hg and 1.8 mm Hg, 
respectively. 
 LAB are also postulated to possess anti-carcinogenic effect via various 
approaches. Gomes and Malcata (1999) postulated that lactobacilli decreased the risk of 
tumour development by reducing the production of bacterial pro-carcinogenic enzymes 
such as β-glucuronidase, nitroreductase and urease. The anti-carcinogenic effects also 
attributed to the production of short-chain fatty acids that lower the colonic pH, and 
subsequently suppressing the growth of pathogenic microorganisms that are involved in 
the production of tumour promoters and pro-carcinogenic (Liong 2008). Another studies 
suggested that tumour suppressing ability is attributed to the binding of mutagens to the 
cell wall skeleton of LAB and the binding of heterocyclic amines by intestinal probiotics 
(Zhang & Ohta 1991; Orrhage et al. 1994). Cabana et al. (2007) reported that the anti-
carcinogenic effect from LAB could be accredited to their ability to enhance the 
intestinal detoxification, transit and immune status, while Singh et al. (1997) indicated 
the anti-carcinogenic effect could attribute to suppression of as-p21 oncoprotein 
expression. In addition, LAB, which possessed anti-neoplastic activity were also shown 
to play an important role in the prevention of colorectal cancer (Boyle et al. 2006). 
15 
 
Regardless of various approaches, several studies have been conducted indicating the 
capability of LAB to exert various degrees of anti-mutagenic activity in the Salmonella 
typhimurium mutagenic assay (Renner & Münzner 1991; Hosoda et al. 1992; Abdelali et 
al. 1995). 
 LAB that colonise the gastrointestinal tract are also responsible in producing 
various nutrients to the host such as vitamins, which are essential for the 
microorganisms’ growth and metabolism (Hooper et al. 2002). Various vitamins such as 
folic acid, niacin, thiamine, riboflavin, pyridoxine, cyanocobalamin, and vitamin K have 
been reported to be synthesised by certain lactobacilli, which are slowly absorbed by the 
host body (Gomes & Malcata 1999). Several studies have reported the ability to 
synthesise B-vitamins via L. lactis and L. bulgaricus fermentation and higher production 
of folic acid, niacin, biotin, pantothenic acid, vitamin B6 and vitamin B12 compared with 
unfermented counterpart (Hugenholtz & Kleerebezem 1999; Kleerebezem & 
Hugenholtz 2003). However, the synthesis ability and concentration of vitamins 
produced are strain dependent. For example, some strains are only capable of 
synthesising biotin but not riboflavin (Biavati & Mattarelli 2006). 
 2.1.3 The Use of Lactic Acid Bacteria Beyond Gut Health 
 Beyond altering and improving the intestinal health, recent emerging studies 
have shown that LAB could exert health effects beyond gut health, such as dermal health 
aspects (Table 2.2), as supported by the gut-brain-skin axis hypothesis of Arck et al. 
(2010).  
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LAB have been reported to act as an immunomodulator that regulate the 
production of cytokines and growth factors such as tumour necrosis factor-alpha, 
interferon-gamma, transforming growth factors, and antibodies (IgA and IgE) for 
improving skin health. For instance, administration of L. rhamnosus GG increased the 
secretion of cytokines such as IL-10 and interferon-gamma in cow milk allergy and 
atopic dermatitis lesions (Pessi et al. 2000; Pohjavuori et al. 2004). Recently, the use of 
LAB has been extended as topical application that directly acts on the skin. Clinical 
studies have reported the promising effects of topical application of whole cell or 
bioactive metabolites from LAB by resuming the host skin homeostasis. In vitro studies 
have demonstrated lysate treatment from lactobacilli and bifidobacterium have increased 
the tight-junction barrier function of keratinocytes via modulating the protein 
components such as claudin 3. Furthermore, L. helveticus-fermented milk was shown to 
promote cell differentiation by enhanced the keratin-10 mRNA expression (Baba et al. 
2006; Sultana et al. 2013). Animal study by Jones et al. (2012) reported that topical 
application of an adhesive gas permeable patch containing nitric oxide gas-producing 
LAB promoted wound closure and subsequently accelerated wound healing in New 
Zealand white rabbit model of ischaemic and infected wounds. Altogether, the current 
available evidences illustrated the potential use of either whole cell or bioactive 
metabolites derived from LAB for improving dermal health. 
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Table 2.2 Clinical evidences of topical applications of whole cell and/or bioactive metabolites from LAB to improve dermal health. 
Methods Remarks Authors 
Adult male BALB/c mice were infected with S. aureus 
(108 CFU/mL) and treated with nisin-containing 
nanofibre dressing for seven days 
Viable cell number of S. aureus in nisin group was 
significantly decreased (102 CFU/wound) and accelerated 
excisional wound closure without observable adverse 
effects 
Heunis et al. 
(2013) 
29 healthy females aged 25-55 years old with mild acne 
lesions were treated with oil in water formulation 
containing 5 % L. plantarum extract twice per day for 
two months 
All participants receiving L. plantarum extract treatment 
significantly reduced skin erythema by 57 % and skin 
redness by 7.5 % 
Muizzuddin et 
al. (2012) 
20 healthy females aged 18-50 years old were treated 
with milk lotion containing 3 % L. plantarum fermented 
rice powder twice per day for one month 
No erythema was observed and nine females showed skin 
brightening effect with improve pigmentary deposit. 
Sawaki et al. 
(2010) 
29 healthy females aged 25-55 years old with sensitive 
skin were treated with cream containing 1 % 
Lactobacillus extract twice per day for two months 
All participants treated with cream containing 1 % 
Lactobacillus extract treatment significantly reduced lactic 
acid sting by 27 % in the first month, and 39 % in the  
second month 
Sullivan et al. 
(2005) 
17 healthy Caucasian volunteers aged 24-47 years old 
were treated with cream containing 0.5 g sonicated 
Strep. thermophilus cells twice per day for seven days 
The lipid barrier of all volunteers was improved, with the 
stratum corneum ceramide levels significantly increased 
from 0.25 – 36 pmol total ceramide/µg protein to 639 
pmol total ceramide/µg protein 
Di Marzio et 
al. (1999) 
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2.2 Human Skin 
 The skin is the largest organ of the body, consisting of roughly 15 % of the total 
body weight and covering an area of 1.7 m2. The skin serves as the primary physical 
barrier that protects the body (underlying tissues) against external environment, as “It 
keeps the outside out and inside in”, as mentioned by Zaidi and Lanigan (2010). The 
skin is constantly exposed to external stresses such as physical, chemical, immune 
pathogen, ultraviolet radiation and free radicals, which damages the skin. Furthermore, 
internal influences such as hormonal changes, immunological status, food intake, and 
physiological stresses could disturb the gastrointestinal homeostasis, which later reflects 
on the skin (Guéniche et al. 2009). The skin is also a major participant in 
thermoregulation and functions as a sensory organ and performs endocrine functions 
such as vitamin D synthesis and peripheral conversion of prohormones (Menon 2002). 
 2.2.1 Skin Structure and Function 
 The skin consists of two distinct layers; the outermost epidermis layer and the 
inner dermis layer. Beneath both epidermis and dermis layers is the subcutaneous fat 
layer (Fig 2.1). The subcutaneous fat layer consists of mainly lobules of fat cells and 
connective tissue septa, which are traversed by nerves and blood vessels and, continuous 
with the collagen of the dermis. This subcutaneous fat layer serves as a heat insulator, 
storage for nutritional energy and cushion that protects the body against trauma. 
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Fig 2.1 Structure of the skin: apocrine glands are found only in the axillae, periareolar 
region, periumbilical area, and anogenital region. Sebaceous glands and hair follicles are 
not found in the palms and soles. Arrector pili muscles are not found on the face. 
Reprinted from Zaidi and Lanigan (2010); with permission from Springer (Licence 
number: 3720130089766) 
 
 The middle dermis layer is the tough fibrous layer, consisting of collagen fibres, 
elastic fibres, fibroblasts, dermal dendrocytes, mast cells, histiocytes, blood vessels, 
nerves, lymphatics, and ground substances such as glucosaminoglycans (Prost-Squarioni 
et al. 2008; Zaidi & Lanigan 2010). The collagen fibres that span within the dermis 
provide tough mechanical support to the skin while the elastic fibres loosely arranged in 
all directions help in the elastic recoil of the skin. Meanwhile, the blood vessels serve 
two major purposes, to help maintain body temperature and to supply nutrients to the 
skin layers. The nerve fibres are responsible for cutaneous sensations such as heat, cold, 
pain, pressure with one end of the nerves extending to the epidermis layer, while the 
other end of the nerves end in specialised effectors in the dermis. The ground substances 
such as glucosaminoglycans has a remarkable important role by assisting the passage of 
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nutrients, hormones, and fluid molecules through the dermis. The glucosaminoglycans 
also support the collagen and elastic tissues, and water holding capacity to prevent 
desiccation (Zaidi & Lanigan 2010). Despite being highly vascular, the dermis layer also 
contains pilosebaceous unit, sweat glands, dermal adipose cells, mast cells, and 
infiltrationg leucocytes (Menon 2002).  
Overlaying the dermis layer is the avascular outer epidermis layers which are 
composed primarily of keratinocytes that undergo keratinisation, which then turn into an 
effective protective barrier and maintain the integrity of the epithelial tissues (Presland 
& Dale 2000; Menon 2002; Zaidi & Lanigan 2010). Meanwhile, other prominent cells 
are melanocytes, Langerhans cells, and Merkels cells. The epidermis obtains its nutrients 
from the dermis blood vessels, as the epidermis does not have any blood vessels. The 
keratinocytes are arranged in different levels of epidermis. The stratified epidermis is 
approximately 100 to 150 µm thick with four distinct layers, namely the stratum 
germinatum (basal cell layer), stratum malpighian, stratum granulosum, and outermost 
stratum corneum layers (Fig 2.2). There is an additional epidermis layer that is only 
present in the palms and soles, namely stratum lucidim that spans between stratum 
corneum and stratum granulosum (Zaidi & Lanigan 2010). 
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Fig 2.2 Epidermal layers: stratum corneum - anucleated cells; stratum lucidum - present 
only in palms and soles; stratum granulosum - epidermal nuclei start disintegrating; 
stratum malpighian - thickest and strongest layer; stratum germinatum - the only cells 
which undergo division. Epidermal cells: keratinocytes - the main cells of the epidermis, 
present in every layer of the epidermis; melanocytes - dendritic pigment producing cells, 
seen with a halo around them under ordinary staining, due to the lack of desmosomes. 
Present amongst the basal cells; langerhans cells - dendritic immunologically competent 
cells, also seen with a halo around them, due to the absence of desmosomes. Present in 
the stratum malpighian; merkel cells - present only in hairless skin; related to the sense 
of touch. These cells can only be seen under an electron microscope. Present amongst 
the basal cells. Reprinted from Zaidi and Lanigan (2010); with permission from Springer 
(Licence number: 3720130089766) 
 
 Stratum germinatum is located at the innermost layer in the epidermis and 
presents as a single layer overlay the basement membrane. They are the only cells of the 
epidermis that divides, subsequently migrating towards upper layers and transform into 
continuous sheets of flattened and anucleated corneocytes at the outermost stratum 
corneum layer (Menon 2002). The upper stratum corneum that shed from the skin 
surface in the form of microscopic scales is balanced by the cells of the basal layer. 
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Typical human stratum corneum has about 18 to 21 layers of corneocytes. The strong 
mechanical stability and chemical resistant in corneocytes were attributed to the 
insoluble bundled keratin filaments that are surrounded by cornified envelope proteins 
filled with inoculcrin, loricrin, filaggrin, and cornified lipid envelope (Proksch & Jensen, 
2012). These cells overlap each other and are held together by firm lipid-rich cement 
composed of ceramides, free saturated fatty acids, and cholesterol that is organised as 
lamellar lipid layers, making stratum corneum prevent the loss of fluids from the body 
and entry of microorganisms and chemicals into the body (Menon 2002; WHO 2009; 
Zaidi & Lanigan 2010).  
 The loss of integrity of a portion of skin as a result of injury or illness need to be 
recovered as soon as possible to prevent bacterial infections and further fluid loss. 
Wound healing is a dynamic biological process that can be divided into three phases, 
namely inflammation, proliferation, and maturation phases that involve various soluble 
mediators, blood cells, extracellular matrix, and parenchymal cells (Singer & Clark 
1999). Wound healing process begins with the blood clot formation that re-establishes 
hemostasis. This has provided an extracellular matrix for cell migration, such as 
neutrophils and macrophages to cleanse the wound area from foreign particles and 
bacteria. In addition, various cytokines and growth factors such as IL-1, TGF, TNF-α, 
and macrophage-derived growth factors were expressed to initiate the proliferation 
phase for the formation of new tissue in wounds (Clark 1996; Riches 1996). During 
proliferation phase, angiogenesis occurs and a provision extracellular matrix is formed 
by fibroblast through excreting collagen and fibronectin. Concurrently, epithelial cells 
continue to proliferate to form a new cover tissue on top. During the maturation phase, 
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the expression of growth factors and cytokines begin to cease and the cells that are no 
longer needed undergo the apoptosis process (Garg 2000; Chang et al. 2004; Midwood 
et al. 2004). 
 2.2.2 Skin Microflora 
 Despite acting as a physical barrier, the skin is also an intricate habitat for many 
bacteria. The use of DNA sequencing and metagenomics enable the identification of 
skin microorganisms and interaction between skin microflora and skin diseases. A total 
of 19 phyla were found from 20 diverse skin sites of 10 healthy humans and identified 
via 16S rRNA gene phylotyping. Most of the identified microorganisms were classified 
into Actinobacteria (51.8 %), Firmicutes (24.4 %), Proteobacteria (16.5 %), and 
Bacteriodetes (6.3 %) (Grice et al. 2009). The anatomic location, local humidity, amount 
of sebum and sweat production, and host’s hormonal status and age greatly influence the 
type and density of bacteria (Aly et al. 1991).  
 Skin microflora can be grouped as commensal, symbiotic, or parasitic relative to 
the host. The use of 16S rRNA gene phylotyping demonstrated Staphylococcus sp., 
Micrococcus sp., Corynebacterium sp., and Propionibacterium sp. are the common 
residents of the skin (Chiller et al. 2001; Findley et al. 2013). Gram-negative bacteria 
such as Pseudomonas sp., Klebsiella sp., and Vibrio sp. are not typical resident skin 
microflora and often associated with cutaneous infections. However, moist intertriginous 
areas allow the growth of Acinetobacter sp. The growth of commensal bacteria was 
supported by the skin by utilising the skin surface sebum as nutrients, which in turn 
maintain skin acescence and prevent the invasion of transient pathogenic bacteria both 
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directly and indirectly (Chiller et al. 2001). For instance, the binding of commensal S. 
epidermidis to keratinocytes prevent adherence of virulent S. aureus, while fatty acid 
released by Propionibacterium acnes from lipid breakdown acidify the environment and 
subsequently inhibit the growth of Streptococcus pyrogenes (Hentges 1993).  
 In addition to bacteria, fungi also represents a major population in normal human 
skin. Topographical mapping using intervening internal transcribed spacer 1 region and 
18S rRNA sequencing revealed that 11 core-body and arm sites of 10 healthy adults 
were dominated by 11 Malassezia sp., with feet sites demonstrated richest fungal 
diversity as compared to other body sites (Findley et al. 2013). Furthermore, a whole 
metagenomic analysis by Foulougne et al. (2012) has discovered the cutaneous viral 
population, the human polyomaviruses in healthy individuals. 
 Alteration in the balance of microflora and skin homeostasis might subsequently 
lead to dermatological diseases. For instance, study by Fadeyibi et al. (2013) 
demonstrated that the Gram-negative bacteria, Pseudomonas aeruginosa, was 
dominating the infected burn wounds in burnt patients. The distribution of the bacteria in 
skin biopsies was different between normal and psoriasis patients. Via pyrosequencing 
targeting the 16S rRNA and variable regions V3-V4, the number of Streptococcus 
pyrogene was significantly higher while the number of staphylococci and 
propionibacteria was significantly lower in skin biopsies of psoriasis patients as 
compared to normal skin (Fahlen et al. 2012).  
 Despite being one of the common residents on the human skin, Staphylococcus 
aureus also take part in atopic dermatitis (AD), a chronic inflammatory skin disease. 
